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Background: Recurrent aphthous stomatitis is a common oral mucosa disease, with no specific etiology. Atopy has 
been implicated in the development of this disease. In this study, the salivary levels of immunoglobulin E (IgE) and 
eosinophil cationic protein (ECP) were measured as allergy-related biomarkers in patients with aphthous stomatitis.
Material and Methods: In this case-control study, non-stimulated saliva was collected from 85 participants and IgE 
and ECP were measured. Data were analyzed in SPSS 20 through the Mann-Whitney test, and p<0.05 was consi-
dered significant.
Results: The salivary levels of IgE and ECP were 1.11±0.65 Iu/ml and 26.93±6.95 ng/ml in the case group and 
0.73±0/39 Iu/ml and 21.97±6.72 ng/ml in the control group. There was a significant difference between the two 
groups in terms of salivary levels of IgE and ECP (p=0.001).
Conclusions: The results showed that patients with oral aphthous had higher levels of salivary IgE and ECP than 
controls. Therefore, measurement of these biomarkers may be useful in the initial evaluation of patients with aph-
thous stomatitis.




Recurrent aphthous stomatitis (RAS) is a common oral 
mucosa disease (1-5) characterized by recurrent ulcers 
limited to the oral cavity without any symptoms of other 
diseases (4). Ulcers are very painful, interfere with ea-
ting, talking, and swallowing and affect the patients’ 
quality of life (6,7). The prevalence of aphthous stoma-
titis depends largely on the study population, although 
a prevalence of 5-25% has been reported (1,6). Studies 
have shown that oral aphthous is more prevalent in 
adult women, people under 40 years of old, whites, non-
smokers, and those with high socioeconomic status (3).
RAS has an unknown etiology (1,8) and numerous fac-
tors have been implicated in its development including 
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familial and genetic factors (9), nutritional, vitamin 
(10,11) and hematologic deficiencies (1,9), allergies 
(11,12), stress (8,13,14), immune reactions (8,9,11,15-
18) and H. pylori infection (18).
Given the possible relationship of allergy and aphthous 
stomatitis, evaluation of allergy-related biomarkers, 
including eosinophil cationic protein (ECP) and im-
munoglobulin E (IgE), can be helpful in patients with 
aphthous stomatitis. ECP is an allergic inflammatory 
mediator, which is released from eosinophils and acti-
vated by IgE (19).
IgE is a type of five immunoglobulin classes in the body 
and plays an important role in the pathogenesis of aller-
gic diseases. There are reports about changes in serum 
IgE levels in patients with aphthous stomatitis and in-
creases in serum IgE levels in Behcet’s disease (12).
Almoznino et al. (12) reviewed the relationship between 
serum levels of IgE and demographic, clinical, and sero-
logical parameters of patients with aphthous stomatitis, 
and found a statistically significant relationship between 
the mean levels of IgE and female gender, age under 12 
years, the onset and frequency of episodes of aphthous, 
and C-reactive protein level (CRP).
So far, no study has been conducted on the salivary le-
vels of ECP in patients with aphthous stomatitis. In a 
study by Jang et al. (20) ECP was higher in people with 
allergic diseases than ECP in patients with non-allergic 
inflammatory diseases. Angelova Fischer et al. (21) ob-
served an increase in serum levels of ECP in the acute 
phase of atopic dermatitis in comparison with the con-
trol group.
Since there may be an association between allergy and 
aphthous stomatitis and given the lack of studies on the 
allergy-related biomarkers in these patients, the present 
study aimed to evaluate these biomarkers in the patients’ 
saliva.
Material and Methods
41 patients with recurrent aphthous stomatitis and 44 
healthy individuals visiting the Zahedan Dental School 
were selected through convenience sampling method ac-
cording to inclusion and exclusion criteria.
-Inclusion criterion in the case group
Occurrence of recurrent aphthous stomatitis at the visi-
ting time.
Experience of at least three times of RAS per years.
Inclusion criterion in the control group
Healthy subjects matched with the case group in terms 
of age and gender.
Exclusion criteria in both groups
1. Any systemic disease, including allergic condition 
such as atopic dermatitis, allergic rhinitis, bronchial as-
thma.
2. Any drug consumption.
3. Pregnancy.
4. Occurrence of other oral mucosal diseases, including 
aphthous like ulcers.
5. Consumption of alcohol and tobacco products.
The study objectives were explained to all participants 
in the case and control groups and written consent was 
obtained from them. Ethical Committee of Zahedan 
University of medical science approved the present 
study (code: IR.ZAUMS.REC.1393.7013). The oral 
mucosa was examined using a disposable mirror under 
the dental unit light. RAS was diagnosed based on the 
following criteria:
Round or ovoid oral ulcers with circumscribed margins 
and a white or yellow pseudo-membrane surrounded by 
a red halo (11).
In addition, the complete medical history and demo-
graphic information of the patient were recorded in a 
questionnaire. Then non-stimulated saliva was collected 
from each person through the spitting method. To this 
end, all patients were asked to avoid eating, drinking, 
and brushing 90 minutes before sampling. All samples 
were collected between 9:00 and 12:00 AM, during 
which the patients were sat in a comfortable position and 
bent slightly forward. Every 1-2 min, they spitted their 
saliva in sterilized test tubes for 10 minutes. The test tu-
bes were sealed with parafilm after the saliva collection, 
encoded, and immediately sent to the biochemistry labo-
ratory. In the laboratory, the saliva was centrifuged for 
10 min at 2000 rpm to separate the debris. The sample 
was transferred to a microtube using a micropipette. The 
microtube was also coded according to the test tube code 
and kept at -80°C for future testing (22).
The salivary levels of IgE and ECP were measured in 
the biochemistry laboratory through ELISA using the 
Pishtaz Teb, Iran, and East Biopharm, china, kits, res-
pectively.
-Data analysis
Data were analyzed using Mann-Whitney test in SPSS 
20. P<0.05 was considered as the significance level.
Results
In this study, 41 patients with recurrent aphthous stoma-
titis (25 males and 16 females) with an average age of 
29 years were selected as the case group and 44 healthy 
subjects (21 males and 23 females) with an average age 
of 27 years were selected as the control group. There 
was no significant difference between the two groups in 
terms of age and gender (Table 1).
Given the abnormal distribution of IgE and ECP levels, 
Mann-Whitney test was used, which revealed a signifi-
cant relationship between recurrent aphthous stomatitis 
and increased salivary levels of IgE and ECP (p<0.0 5).
Discussion
Recurrent aphthous stomatitis is a common oral mucosa 
disease (1-5) with still unknown etiology (1,8).
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Variable Case group Control group P value
IgE level Iu/ml 1.11±0.65 0.73±0.39 0.001
ECP level ng/ml 26.93±6.95 21.97±6.72 0.001
Age(years) 29.3±7.43 27.5±7.87 0.283
Gender (female/male) 16/25 23/21 0.22
Table 1: General baseline characteristics of the study groups.
However, familial and genetic factors, immune system 
dysregulation, nutritional deficiencies, trauma, infec-
tious agents (23) systemic diseases, stress and allergy 
to certain foods have been implicated in its occurrence 
(24). Several studies suggested the implication of ato-
py in the development of recurrent aphthous stomatitis 
(8,25,26). Exposure to some nutritional compounds such 
as chocolate, gluten, cow milk, and food colors can in-
duce a pro-inflammatory cascade in the affected popula-
tion. Dietary restriction has resulted in clinical improve-
ment in some studies (8); however, Tarakji et al. (10) did 
not confirm the role of the diet in the occurrence of RAS. 
Given the possible role of allergy in the development of 
these ulcers, the present study aimed to investigate sa-
livary IgE and ECP as allergy-related biomarkers. ECP 
is an allergic inflammatory mediator, which is released 
from eosinophils and activated by IgE. This leukocytic 
protein is toxic to neurons, and epithelial cell membra-
ne and its levels do not directly correlate with the eosi-
nophil count in peripheral blood (19).
Various studies have shown the association between 
ECP and allergic diseases (19-21,27-29).
Keles et al. (19) stated that serum levels of ECP and IgE 
are associated with the persistence of wheezing in peo-
ple with asthma. Jang et al. (20) studied the levels of 
ECP in people with allergic diseases and showed that 
measurement of ECP is helpful in monitoring allergic di-
seases. This was confirmed in a study by Koh et al. (27)
Angelova-Fischer et al. (21) compared the serum levels 
of ECP and several other parameters in assessing the se-
verity of atopic dermatitis in 21 patients in the acute pha-
se and after complete remission. Their results indicated 
that the serum levels of these parameters were signifi-
cantly higher in the acute phase of atopic dermatitis than 
in the control group and decreased along with symptoms 
improvement.
Schmekel et al. (28) attributed the increase in the sali-
vary levels of ECP in asthmatic patients to the presence 
of eosinophils in the oral mucosa and salivary glands of 
asthmatic patients and the increased oral mucosal per-
meability due to harmful eosinophilic activity or increa-
sed ECP levels in the peripheral circulation. In a study 
by Lee et al. (29), restricted consumption of ready-made 
foods led to a reduction in serum ECP levels in children 
with atopic dermatitis and improved clinical symptoms.
IgE is one of the five isotypes of human immunoglobu-
lins that plays a major role in the pathogenesis of several 
allergic diseases. Identification of IgE-coated lympho-
cytes in peripheral blood and RAS ulcers and increased 
number of mast cells in ulcers biopsy with symptoms of 
their activity and degranulation, indicating the role of 
these cells in the pathogenesis of RAS (12).
Almoznino et al. (12) showed an increase in serum IgE 
levels in these patients.  Also, serum IgE levels were sig-
nificantly associated with female sex, younger age, and 
early onset of RAS episodes. Fornasa and Gallina (25). 
examined the association between RAS and atopy in 39 
patients with RAS in terms of their personal and fami-
lial history of atopy, serum IgE levels, skin prick test, 
skin patch test, and specific IgE Ab, and found clinical 
and laboratory signs of atopy in 27 patients. Ruan et al. 
(23) also reported that there is an association between 
RAS and atopy and showed that the serum levels of IgE 
were significantly higher in patients with RAS than in 
controls.  In the present study, there was a significant di-
fference in the salivary IgE between two groups, which 
was consistent with the mentioned researches. Our study 
is one of the few studies that investigated the salivary le-
vels of IgE and ECP in patients with RAS; and due to the 
lack of similar study and difference of research methods, 
it was impossible to compare the results; this was one of 
the limitations of the present study.
Saliva is the result of serum outflow from the salivary 
glands supplying blood vessels, and diseases induced 
changes in the serum are reflected in the saliva; therefo-
re, the use of saliva seems logical given  its more com-
fortable, collection and maintenance, lower risk of HIV 
and hepatitis transmission, and cost-effectiveness (30).
Conclusions
The results of this study showed that patients with oral 
aphthous had higher salivary levels of IgE and ECP than 
controls. Therefore, the levels of these biomarkers can 
be determined for the initial evaluation of patients with 
aphthous stomatitis.
Suggestions
It is recommended to carry out a study with a larger 
sample size to investigate the relationship between the 
demographic, clinical, and serum parameters of the pa-
tients and the salivary and serum levels of these biomar-
kers. 
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